Neocannbio, a technical subsidiary of the Korea Institute of Science and Technology (KIST) and the first company in Korea to develop treatments for intractable diseases and manufacture various high-purity cannabinoid raw materials, along with building a cannabinoid library of medical marijuana hemp based on its own natural product processing facilities and technology to develop new drugs derived from natural products.